Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

4.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.3K
Clinical Trials01:16

Clinical Trials

10.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.0K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.5K
Vaccinations01:51

Vaccinations

49.6K
Overview
49.6K
Humoral Immune Responses01:36

Humoral Immune Responses

80.9K
Overview
80.9K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

86
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
86

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating environmental and clinical surveillance for typhoid: insights from a prospective wastewater surveillance study in urban India.

The Lancet. Microbe·2026
Same author

Double burden of malnutrition by mid-childhood in an Indian birth cohort: a longitudinal study (2010-2021).

The Lancet regional health. Southeast Asia·2026
Same author

Kinetics of Enteric Pathogen Quantity During Acute Diarrhea in Children in Resource-Limited Settings.

Open forum infectious diseases·2026
Same author

Impact of Asymptomatic Enteroaggregative Escherichia coli Infection and Co-Pathogen Burden on Intestinal Barrier Function, Linear Growth, and Cognitive Development in Early Childhood: Insights from a Birth Cohort Study.

The American journal of tropical medicine and hygiene·2026
Same author

The future of diagnostics in Africa.

Nature medicine·2026
Same author

Community-wide deworming strategies to reduce high hookworm burden in endemic communities: Results from a cluster randomized trial in Southern India.

PLoS neglected tropical diseases·2026

Related Experiment Video

Updated: Nov 27, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.0K

Human challenge trials in vaccine development.

Amrita Sekhar1, Gagandeep Kang1

  • 1Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India.

Seminars in Immunology
|December 2, 2020
PubMed
Summary

Human challenge studies accelerate vaccine development by revealing infection responses and vaccine performance. Optimizing challenge strains and study locations is key to maximizing their value.

Keywords:
Controlled human infection modelsHuman challenge studiesHuman infection studiesVaccines

More Related Videos

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.0K
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

10.1K

Related Experiment Videos

Last Updated: Nov 27, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.0K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.0K
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

10.1K

Area of Science:

  • Infectious diseases and vaccinology
  • Clinical trial methodologies

Background:

  • Human challenge studies (HCS) are increasingly vital for accelerating vaccine development.
  • These studies offer unique insights into host responses to infection and vaccine efficacy.
  • Advancements in ethical review, study conduct, and investigative tools (e.g., immunophenotyping, glycobiology) enhance HCS potential.

Purpose of the Study:

  • To highlight the growing importance of human challenge studies in vaccine research.
  • To discuss the factors enabling greater data generation from these studies.
  • To identify remaining challenges for optimizing the value of HCS in vaccine development.

Main Methods:

  • Review of current trends and capabilities in human challenge studies.
  • Identification of enabling factors such as streamlined ethics and advanced investigative tools.
  • Analysis of persistent challenges in strain standardization, study site selection, and data integration.

Main Results:

  • HCS provide unparalleled understanding of infection dynamics and vaccine performance.
  • Improved ethical frameworks and technological tools amplify the potential of HCS.
  • Significant opportunities exist to enhance data value through addressing logistical and methodological hurdles.

Conclusions:

  • Human challenge studies are a powerful tool for rapid vaccine development.
  • Standardization of challenge agents and strategic study site selection are crucial.
  • Integrating clinical and laboratory findings is essential for maximizing HCS impact on vaccine innovation.